首页> 外国专利> VACCINE FOR LYME ARTHRITIS, ITS PREPARATION, MONOCLONAL ANTIBODY, PATHOGENIC BOLERIA BULGDOLFERI STRAIN, ANTIGEN, RECOMBINANT DNA, RECOMBINANT VECTOR, PREPARATION OF ANTIGEN AND ISOLATION AND RECULTIVATION OF SAID BORRELIA BULGDOLFERI SYSTEM

VACCINE FOR LYME ARTHRITIS, ITS PREPARATION, MONOCLONAL ANTIBODY, PATHOGENIC BOLERIA BULGDOLFERI STRAIN, ANTIGEN, RECOMBINANT DNA, RECOMBINANT VECTOR, PREPARATION OF ANTIGEN AND ISOLATION AND RECULTIVATION OF SAID BORRELIA BULGDOLFERI SYSTEM

机译:莱姆病关节炎疫苗,其制备,单克隆抗体,致病性球孢白僵菌菌株,抗原,重组DNA,重组载体,抗原的制备及沙门氏菌球茎系统的分离和回收

摘要

The invention relates to a passive vaccine against Lyme disease, which contains one or more monoclonal antibodies specific for the 31 kD antigen (OspA) and/or the 34 kD antigen (OspB) of B. burgdorferi and, in immunodeficient experimental animals which have been infected with viable pathogenic B. burgdorferi organisms, prevents the development of arthritis, pancarditis and hepatitis. The invention also relates to a process for obtaining the vaccine according to the invention, to the hybridoma cell lines ECACC 89 09 1302, ECACC 90050405, ECACC 90050406 and ECACC 90050407 which secrete antibodies according to the invention, and to the pathogenic B. burgdorferi strain ZS7 (DSM 5527). The invention likewise relates to an antigen from B. burgdorferi, which undergoes an immune reaction with an antibody according to the invention, to a process for obtaining antigens according to the invention and to active vaccines against Lyme disease which contain an antigen according to the invention as essential component. The invention finally relates to a process for the isolation and recultivation of pathogenic B. burgdorferi organisms from immunodeficient experimental animals.
机译:本发明涉及一种抗莱姆病的被动疫苗,其包含一种或多种对伯氏疏螺旋体的31kD抗原(OspA)和/或34kD抗原(OspB)具有特异性的单克隆抗体,并且在免疫缺陷的实验动物中已被证实。感染了可感染的病原性伯氏疏螺旋体生物,可预防关节炎,全心炎和肝炎的发展。本发明还涉及获得根据本发明的疫苗的方法,涉及分泌根据本发明的抗体的杂交瘤细胞系ECACC 89 09 1302,ECACC 90050405,ECACC 90050406和ECACC 90050407,以及致病性伯氏疏螺旋体。 ZS7(DSM 5527)。本发明同样涉及来自伯氏疏螺旋体的抗原,其与根据本发明的抗体发生免疫反应,涉及获得根据本发明的抗原的方法,以及涉及包含本发明的抗原的抗莱姆病的活性疫苗。作为必不可少的组成部分。本发明最后涉及一种从免疫缺陷实验动物中分离和再培养病原性伯氏疏螺旋体的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号